Seattle Genetics CEO Clay Siegall's comp package soars to $18.1M, rivaling Big Pharma chiefs

After taking shareholders on something of a roller coaster ride last year, Seattle Genetics CEO Clay Siegall rewarded himself with a compensation package that swelled to more than twice the size of his financial reward for 2017.